72 related articles for article (PubMed ID: 14986187)
1. [Recurrent pseudotumoral multiple sclerosis].
Gonzalez-Delgado M; Tunon A; Guisasola LM; Mateos V
Neurologia; 2004 Mar; 19(2):83-4. PubMed ID: 14986187
[No Abstract] [Full Text] [Related]
2. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
Alvarez-Cermeño JC; Masjuan J; Villar LM
N Engl J Med; 2005 Oct; 353(16):1744-6; author reply 1744-6. PubMed ID: 16240475
[No Abstract] [Full Text] [Related]
3. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
5. Narcolepsy-like syndrome in multiple sclerosis.
Vetrugno R; Stecchi S; Plazzi G; Lodi R; D'Angelo R; Alessandria M; Cortelli P; Montagna P
Sleep Med; 2009 Mar; 10(3):389-91. PubMed ID: 18550429
[No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging as a surrogate for treatment effect on multiple sclerosis relapses.
Arnold DL; Goodin DS
Ann Neurol; 2009 Mar; 65(3):237-8. PubMed ID: 19334057
[No Abstract] [Full Text] [Related]
7. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
Portaccio E; Zipoli V; Goretti B; De Stefano N; Amato MP
Mult Scler; 2009 Mar; 15(3):403; author reply 404. PubMed ID: 19244397
[No Abstract] [Full Text] [Related]
8. Is it a relapse?
Flohil M; Verheul G; Schuuring J
Mult Scler; 2009 Apr; 15(4):523-4. PubMed ID: 19324984
[No Abstract] [Full Text] [Related]
9. Concurrent occurrence of multiple sclerosis and primary CNS lymphoma: a case report.
Burgetova A; Seidl Z; Vaneckova M; Jakoubkova M
Neuro Endocrinol Lett; 2008 Dec; 29(6):867-70. PubMed ID: 19112415
[TBL] [Abstract][Full Text] [Related]
10. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Metz LM; Zhang Y; Yeung M; Patry DG; Bell RB; Stoian CA; Yong VW; Patten SB; Duquette P; Antel JP; Mitchell JR
Ann Neurol; 2004 May; 55(5):756. PubMed ID: 15122721
[No Abstract] [Full Text] [Related]
11. Hypersexual sensations and behavior in a multiple sclerosis exacerbation: a case report.
Yang CC; Severson B; Bowen JD
Int J Impot Res; 2004 Aug; 16(4):382-4. PubMed ID: 15014553
[No Abstract] [Full Text] [Related]
12. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
13. Midbrain lesions and paroxysmal dysarthria in multiple sclerosis.
Blanco Y; Compta Y; Graus F; Saiz A
Mult Scler; 2008 Jun; 14(5):694-7. PubMed ID: 18566032
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Bar-Or A; Calabresi PA; Arnold D; Markowitz C; Shafer S; Kasper LH; Waubant E; Gazda S; Fox RJ; Panzara M; Sarkar N; Agarwal S; Smith CH
Ann Neurol; 2008 Mar; 63(3):395-400. PubMed ID: 18383069
[TBL] [Abstract][Full Text] [Related]
15. Pseudotumoral forms of multiple sclerosis: report of 14 cases and review of the literature.
Mauri-Fábrega L; Díaz-Sánchez M; Casado-Chocán JL; Uclés-Sánchez AJ
Eur Neurol; 2014; 72(1-2):72-8. PubMed ID: 24903642
[TBL] [Abstract][Full Text] [Related]
16. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Caniatti ML; Baldi E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2007 Dec; 192(1-2):219-25. PubMed ID: 17997167
[TBL] [Abstract][Full Text] [Related]
17. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
Rudick RA; Lee JC; Simon J; Fisher E
Ann Neurol; 2006 Aug; 60(2):236-42. PubMed ID: 16786526
[TBL] [Abstract][Full Text] [Related]
18. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting.
Eissa A; Lebel RM; Korzan JR; Zavodni AE; Warren KG; Catz I; Emery DJ; Wilman AH
J Magn Reson Imaging; 2009 Oct; 30(4):737-42. PubMed ID: 19787716
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.
Massacesi L; Parigi A; Barilaro A; Repice AM; Pellicanò G; Konze A; Siracusa G; Taiuti R; Amaducci L
Arch Neurol; 2005 Dec; 62(12):1843-7. PubMed ID: 16344342
[TBL] [Abstract][Full Text] [Related]
20. Dysarthria and dysphagia due to the opercular syndrome in multiple sclerosis.
Pender MP; Ferguson SM
Mult Scler; 2007 Jul; 13(6):817-9. PubMed ID: 17613613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
